Technical Analysis for DARE - Dare Bioscience, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Volume Surge | Other | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 9 hours ago |
Gap Down Closed | about 10 hours ago |
Rose Above Lower Bollinger Band | about 10 hours ago |
Up 1% | about 10 hours ago |
5x Volume Pace | about 10 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 08/08/2024
Dare Bioscience, Inc. Description
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Drugs Birth Control Vagina Women's Health Diaphragm Hormonal Contraception Medroxyprogesterone Acetate
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.0376 |
52 Week Low | 3.24 |
Average Volume | 69,832 |
200-Day Moving Average | 4.82 |
50-Day Moving Average | 4.64 |
20-Day Moving Average | 5.12 |
10-Day Moving Average | 4.86 |
Average True Range | 0.58 |
RSI (14) | 21.26 |
ADX | 34.87 |
+DI | 9.27 |
-DI | 56.39 |
Chandelier Exit (Long, 3 ATRs) | 4.49 |
Chandelier Exit (Short, 3 ATRs) | 5.00 |
Upper Bollinger Bands | 6.18 |
Lower Bollinger Band | 4.07 |
Percent B (%b) | -0.13 |
BandWidth | 41.11 |
MACD Line | -0.17 |
MACD Signal Line | 0.02 |
MACD Histogram | -0.1894 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.04 | ||||
Resistance 3 (R3) | 4.99 | 4.54 | 4.83 | ||
Resistance 2 (R2) | 4.54 | 4.22 | 4.56 | 4.76 | |
Resistance 1 (R1) | 4.16 | 4.02 | 4.35 | 4.21 | 4.69 |
Pivot Point | 3.71 | 3.71 | 3.80 | 3.73 | 3.71 |
Support 1 (S1) | 3.33 | 3.39 | 3.52 | 3.38 | 2.89 |
Support 2 (S2) | 2.88 | 3.19 | 2.90 | 2.82 | |
Support 3 (S3) | 2.50 | 2.88 | 2.75 | ||
Support 4 (S4) | 2.55 |